Ionis Announces Submission of Marketing Authorization Application for Inotersen to the EMA Post author:Sam Post published:November 2, 2017 Post category:BioPharma The MAA will be reviewed under the EMA’s Accelerated Assessment program. Source: BioSpace You Might Also Like Google's Verily Launches 10,000-Person Study to 'Create a Map of Human Health' April 18, 2017 <b>Harmony Biosciences</b> Gains U.S. Rights to Pitolisant, Raises $270 Million October 5, 2017 MacroGenics Announces Date Of First Quarter 2017 Financial Results Conference Call April 25, 2017
